Riverstone (AP4) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
26 Nov, 2025Executive summary
Specializes in high-tech cleanroom gloves, premium healthcare gloves, and cleanroom consumables, serving electronics, semiconductor, pharmaceutical, and healthcare sectors.
Operates through a diversified group structure with manufacturing and sales presence in Malaysia, China, Thailand, Singapore, and the Philippines.
Revenue for 3Q2025 was RM247.5 million, down 17.1% year-over-year, with gross profit margin declining to 30.9% from 34.7% due to higher cost of sales.
Profit before tax and profit after tax for 3Q2025 fell by 25.6% and 28.0% respectively compared to 3Q2024.
For the nine months ended 30 September 2025, revenue was RM744.6 million, a decrease from RM794.8 million in the prior year period.
Financial highlights
9M FY2025 revenue was RM744.6 million, down 6.3% year-over-year; Q3 FY2025 revenue rose 1.1% sequentially.
9M FY2025 gross profit was RM224.5 million, down 25.3% year-over-year; Q3 gross profit up 16.5% sequentially.
9M FY2025 net profit was RM153.8 million, down 29.1% year-over-year; Q3 net profit up 14.7% sequentially.
Cash and cash equivalents stood at RM660.9 million as of 30 September 2025, down from RM715.1 million at year-end 2024.
Dividends paid in 9M2025 totaled RM222.3 million.
Outlook and guidance
Focus on R&D, flexible production, and ESG initiatives to drive future growth.
The business faces ongoing challenges from price competition, currency fluctuations, volatile raw material prices, and increased production costs.
US tariffs remain in effect and are being monitored for impact.
Committed to sustainable practices, including water and electricity savings, waste reduction, and renewable energy adoption.
Management is taking steps to mitigate risks from these external factors.
Latest events from Riverstone
- FY2025 saw lower revenue and profit year-over-year, but Q4 showed sequential improvement.AP4
Q4 20259 Mar 2026 - Profits and margins fell as costs rose, but ESG and innovation efforts continued.AP4
Q2 202518 Aug 2025 - Profit and revenue surged, but cost and competition pressures persist.AP4
Q3 202413 Jun 2025 - Net profit surged 54.6% in 1H FY2024 on higher revenue and strong glove demand.AP4
H1 202413 Jun 2025 - Net profit dropped 21.8% year-over-year despite higher revenue and a strong dividend payout.AP4
Q1 20256 Jun 2025 - Revenue and profit rose in FY2024, but margin pressures and industry headwinds persist.AP4
H2 20245 Jun 2025